A clinical trial to evaluate the effect of Rasayana Avaleha during pregnancy W.S.R. to the fetal outcome
a healthy environment to the fetus in the womb is the basic necessity for which health status of the mother is very essential. To achieve this, Ayurveda has prescribed Garbhini Paricharya [2] (antenatal regimen), Masanumasika Pathya (month wise diet regimen), etc., which all together strengthens the Dhatu (tissue) of the mother, thereby a qualitative nourishment of the fetus takes place which directly influences the health and immunity of the fetus.
Especially in the 6 th and 7 th month regimen of Masanumasika Garbhini Pathya, [3] administration of Madhura group of drugs endowed with Rasayana, strengthening, anabolic, etc., properties has been mentioned. Rasayana brings about Apyayana (replenish) of Rasa Dhatu [4] (Rasa tissue) as well as does Rasa Samvahana (proper circulation of Rasa). Considering the significance of tissue nourishment [2] and Rasayana effect by the Madhura Rasa (drugs predominant with sweet taste), this concept is utilized in pregnancy which adds to the excellence of maternal nutrition and fetal nourishment. This medium of Uttama Poshana (quality nourishment) contributes to Prashasta Dhatu Nirmana [5] (formation of superior tissues) in the pregnant woman as well as in the fetus.
Madhura rasa is Ajanma Satmya (conducive throughout life). [6] Supplementing the fetus in the womb with Madhura Rasa through maternal diet, may facilitate the fetus to gain excellent Dhatu, Ojas (essence on all the Dhatu), Virya (vitality), Bala (strength), Varna (complexion), etc., from the very beginning itself and thereby, it can attain Ayushya (longevity), Tarpana (nourishment), Jivana (promoting life) and Balya (stregthening) qualities. [6] Rasayana in Garbhini provides health and nourishment both to the mother and the fetus, maintains the internal environment, boost up the immunity right from the fetal life so as to prepare the fetus for its likely adult environment in long term. Accordingly, this clinical trial is planned and is compared with the routine antenatal care followed in contemporary science, i.e., iron and calcium (IC) supplementation.
Subjects and Methods

Source of data
Pregnant women fulfilling the inclusion criteria were selected from outpatient department of SDM Ayurveda Hospital, Udupi, Karnataka, for the study. Parameters of signs, symptoms and investigations were scored on basis of standard method and were analyzed statistically. The trial was registered in CTRI (Reg. No. CTRI/2016/10/007373) and institutional ethical clearance was also obtained (SDMCAU/ACA-49/EC12/ [11] [12] .
Study design
It is a randomized comparative clinical study with pretest and posttest design. Randomization was done by lottery method.
Inclusion criteria
• Both primi-and multi-gravida in their 20-24 weeks of pregnancy (Completing 5 th month of pregnancy) • Patients in the age group between 20 and 35 years. 
Treatment protocol
Total thirty patients were registered and were randomly placed in 2 groups irrespective of age, caste, religion, etc. Details of grouping and posology are mentioned in Table 1 . Dietary instructions were given to both the groups.
Preparation of Rasayana Avaleha
Those Madhura drugs which are seen common in Madhura Gana (group of drugs having Madhura properties) mentioned in Brihat Trayi texts [7] [8] [9] and having immunomodulatory, Rasayana actions were given priority and made into Avaleha form with further addition of Ghrita (ghee), Khanda Sharkara (sugar candy) and Prakshepaka Dravya (additives for enhancing digestion and assimilation) [ 
Statistical analysis
Paired t-test was adapted to assess the changes in the values before and after treatment within the group. Unpaired t-test to compare between two groups.
Results
Effect of the drugs on fetal growth parameters (ultrasonography parameters)
USG biometry of the fetus is now the gold standard for assessing fetal growth. [10] BPD and FL showed statistical significant result in the trial group [Table 3 ]. HC, AC though significant in both the groups, values of trial group were on the higher side. There was a statistically significant increase in the EFBW in the study group when compared to the control group.
Effect of the drugs on fetal outcome
Birth weight
It is a very crude yet a good measure of fetal growth and nutrition. [11] In this study, the birth weight in the trial group was statistically significant and none of babies in Rasayana group were under weight.
Fetal immunoglobulin G
The cord blood sample taken for studying fetal IgG showed increased values in trial group when compared with control group.
Neonatal physiological jaundice
Neonatal jaundice though was not initially included in the assessment criteria, by observation, it was found that the incidence of physiological jaundice was seen only in 2 babies, requiring phototherapy for a maximum of 1-2 days in the trial group whereas in the control group, 11 babies presented with neonatal jaundice, requiring 2-4 days of phototherapy [ Table 4 ].
Discussion
Fetal ultrasonography parameters
The observations of the USG parameters indicate that the Rasayana Avaleha (RA) is quite more effective when compared with the conventional methods in promoting the fetal growth. Significant EFBW may be by the superior quality of nutrition supplemented by the Avaleha which possessed Balya, Brumhana (nourishing), Medhya (nootrophic) effect.
Birth weight
Significant increase in the fetal birth weight is by the efficient nutritional supplement provided by the RA bestowed with the attributes that enhances growth and nourishment to all the Dhatu, thus protecting the fetus from the complications of low birth weight. Feeding the pregnant lady with high amounts of sweets, ghee, etc., containing quite large amount of calories, carbohydrates, proteins and fats, according to the modern concepts may give rise to the development of complications such as diabetes, big baby or obese baby. Obese and healthy build up are two different entities. By observation, we can substantiate that the Garbhini supplemented with RA neither gave birth to an obese or big baby nor developed any diabetic condition, in contrast to the normal belief that high supplementation of Ghrita and Madhura Ahara induces obesity or other metabolic complications. The study drug gave rise to a healthy range of birth weight.
Fetal immunoglobulin G
Increase in the fetal IgG level suggests that the trial drug possessed immunomodulatory activity improving the maternal immunity which inturn directly influences the fetal immunity as the immunoglobulin is passively transferred to fetus by the mother during pregnancy. [12] Humoral immunity also increases passive immunity.
In the RA group, maternal antibodies are transferred through the placenta to the fetus abundantly which caused an increase in the fetal immunoglobulin as well.
Continuation of the drug up to the delivery would have further increased the immunoglobulin significantly.
Physiological jaundice
Neonatal jaundice is mostly seen in immaturity of liver, reduced red blood cell life span, less active liver enzymes and presence of infection conditions. [13] Factors responsible for curtailing the neonatal jaundice in the trial group could be the growth of the fetus in a congenial environment, lack of infections due to the action of RA possessing Rasayana, Jivaniya (life promoting), Balya and specially Yakrut Uttejaka (enhancing the liver function) properties.
Probable mode of action
Balya and Brumhana (anabolic) effect of the drugs Mudgaparni, Mashaparni, Bala, Kharjura, Draksha, Ashwagandha, Shatavari, Vamshalochana, Jivanti and Kshira [14] present in the RA, could be the strong basis for a significant increase in fetal growth parameters and significant fetal birth weight. As fetus is in the earliest stage of development, where Sarva Dhatu (all body tissues) are in the form of budding, supplementing Balya and Brumhana drugs will ensure the proper nourishment and healthy growth in the future.
Shatavari possessing the Medhya property may enhance the 6 th month attribute, i.e., the development of Buddhi [3] (intellect). It has effect on cerebral circulation and may enhance oxygen consumption and glucose utilization by the brain cells. [15, 16] Thus, it may exert specific action on the memory and intellect of the baby . As it shows pharmacological action similar to the nootropic agents, it may bring positive effect on higher mental functions. [17] Mashaparni, Bala, Shatavari, Jivanti and Vamshalochana act as Rakta Shodhaka [18] (blood purifier) and improve the Varna (complexion) of fetus and pregnant woman counteracting the Varna Haani [19] (loss of complexion) which is anticipated in the 6 th month of pregnancy. [20] The Prajasthapana [21] 
Conclusion
RA is a comprehensive and specialized regimen capable of providing healthful longevity by acting at the level of Rasa (nutrition), Agni (digestion and metabolism) and Srotas, enabling to procure the best qualities of different Dhatus. Unlike merely fulfilling the IC needs in pregnancy as in IC group, Rasayana drugs act as an all-rounder in providing nutrition and in building healthy tissues for the overall growth and development right from the intrauterine period. Administering RA in Garbhini is apt as it increases bioavailability of better quality nutrients through which better nourishment to the fetus can be expected. The study proved to have a significant increase in the fetal birth weight in the Rasayana group. Furthermore, the incidence of physiological jaundice was efficiently curbed in Rasayana group when compared to the large number of incidence in the IC supplement group. There was an increase in the fetal IgG in the trial group proving the definite role of immunomodulatory effect of the RA.
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